Correlation Between ABIVAX Société and Innovator Equity

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ABIVAX Société and Innovator Equity at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ABIVAX Société and Innovator Equity into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ABIVAX Socit Anonyme and Innovator Equity Ultra, you can compare the effects of market volatilities on ABIVAX Société and Innovator Equity and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ABIVAX Société with a short position of Innovator Equity. Check out your portfolio center. Please also check ongoing floating volatility patterns of ABIVAX Société and Innovator Equity.

Diversification Opportunities for ABIVAX Société and Innovator Equity

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between ABIVAX and Innovator is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding ABIVAX Socit Anonyme and Innovator Equity Ultra in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innovator Equity Ultra and ABIVAX Société is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ABIVAX Socit Anonyme are associated (or correlated) with Innovator Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innovator Equity Ultra has no effect on the direction of ABIVAX Société i.e., ABIVAX Société and Innovator Equity go up and down completely randomly.

Pair Corralation between ABIVAX Société and Innovator Equity

Assuming the 90 days horizon ABIVAX Socit Anonyme is expected to under-perform the Innovator Equity. In addition to that, ABIVAX Société is 6.88 times more volatile than Innovator Equity Ultra. It trades about -0.09 of its total potential returns per unit of risk. Innovator Equity Ultra is currently generating about 0.17 per unit of volatility. If you would invest  3,320  in Innovator Equity Ultra on September 1, 2024 and sell it today you would earn a total of  262.00  from holding Innovator Equity Ultra or generate 7.89% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy99.21%
ValuesDaily Returns

ABIVAX Socit Anonyme  vs.  Innovator Equity Ultra

 Performance 
       Timeline  
ABIVAX Socit Anonyme 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ABIVAX Socit Anonyme has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, ABIVAX Société is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
Innovator Equity Ultra 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Innovator Equity Ultra are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, Innovator Equity is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

ABIVAX Société and Innovator Equity Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ABIVAX Société and Innovator Equity

The main advantage of trading using opposite ABIVAX Société and Innovator Equity positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ABIVAX Société position performs unexpectedly, Innovator Equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovator Equity will offset losses from the drop in Innovator Equity's long position.
The idea behind ABIVAX Socit Anonyme and Innovator Equity Ultra pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Stocks Directory
Find actively traded stocks across global markets
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios